By Counterforce Health Team in Stelara (ustekinumab) —

How to Get Stelara (Ustekinumab) Covered by Blue Cross Blue Shield in Ohio: Complete 2024 Guide with Forms and Appeals

Answer Box: Getting Stelara Covered by BCBS Ohio

Blue Cross Blue Shield of Ohio (Anthem) requires prior authorization for Stelara (ustekinumab) with step therapy requirements. Your fastest path to approval: 1) Verify your specific formulary status via the Anthem provider portal, 2) Submit PA with TB screening (within 12 months), documented prior therapy failures, and disease severity scores, 3) If denied, file internal appeal within 180 days, then external review through the Ohio Department of Insurance (1-800-686-1526). Ohio's step therapy override law requires approval if preferred drugs are contraindicated, previously failed, or you're stable on current therapy.

Table of Contents

Why Ohio State Rules Matter

Ohio has some of the strongest patient protections in the country for specialty medications like Stelara. Under Ohio Revised Code § 3901.832, insurers must grant step therapy exemptions within 10 days (48 hours for urgent cases) if you meet specific criteria. This applies to state-regulated plans, including most individual and small group BCBS policies.

These protections work alongside your BCBS plan's formulary policies, giving you multiple pathways to coverage. Understanding both your plan's requirements and Ohio's override protections can significantly improve your approval odds.

Note: Self-funded employer plans (ERISA) may not follow state law but often align voluntarily. Check with your HR department or BCBS customer service to confirm which rules apply to your specific plan.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Timeline
Prior Authorization Required before dispensing Anthem provider portal 72 hours standard, 24-72 hours urgent
Step Therapy Must try preferred drugs first Clinical criteria documents 10 days for override (Ohio law)
TB Screening Negative test within 12 months Lab results required Before initial approval
Disease Severity PASI ≥10, BSA ≥10%, or equivalent Provider documentation With PA submission
Specialty Pharmacy CVS Caremark network Post-approval enrollment 5-7 business days
Internal Appeal First level after denial Member services 180 days to file
External Review Independent medical review Ohio DOI 180 days after final denial

Step-by-Step: Fastest Path to Approval

1. Verify Your Plan's Formulary Status

Who: You or your clinic staff
What: Call BCBS member services (number on your card) or check the Anthem provider portal
Timeline: 15 minutes
Tip: Ask specifically about Stelara's tier status, PA requirements, and any quantity limits

2. Gather Required Documentation

Who: Your healthcare provider
What: Collect all supporting evidence before submitting
Timeline: 1-2 days

Essential documents:

  • TB screening results (TST, IGRA, or chest X-ray within 12 months)
  • Disease severity scores (PASI for psoriasis, CDAI for Crohn's)
  • Prior therapy records with specific dates, doses, and failure reasons
  • Specialist consultation notes (dermatologist, gastroenterologist, rheumatologist)

3. Submit Prior Authorization

Who: Your prescribing physician
What: Complete PA form via Anthem provider portal or fax to CVS Caremark
Timeline: 72 hours for standard review, 24-72 hours for urgent
Include: All documentation from step 2 plus ICD-10 codes and dosing plan

4. Track Your Request

Who: You or clinic staff
What: Follow up via provider portal or member services
Timeline: Check status after 48 hours
Tip: Document all phone calls with reference numbers and representative names

5. If Denied, File Internal Appeal Immediately

Who: You or your provider
What: Submit appeal with additional evidence
Timeline: Must file within 180 days of denial
Strategy: Add new clinical evidence, peer-reviewed studies, or specialist letters

6. Request External Review if Internal Appeal Fails

Who: You
What: File with Ohio Department of Insurance
Timeline: Within 180 days of final internal denial
Contact: 1-800-686-1526

7. Consider Peer-to-Peer Review

Who: Your physician
What: Request direct conversation with BCBS medical director
Timeline: Usually within 1-2 business days
Success rate: Higher when combined with strong clinical documentation

Ohio Step Therapy Protections

Ohio law provides three automatic exemptions from step therapy requirements:

Contraindication Exception

If the required step therapy drug is contraindicated per FDA prescribing information, BCBS must approve your override within 10 days (48 hours if urgent).

Example documentation: "Patient has active hepatitis B infection. Per Stelara FDA label, TNF inhibitors like adalimumab are contraindicated due to reactivation risk."

Prior Failure Exception

If you previously tried the required drug and it was discontinued due to lack of efficacy or adverse effects, you qualify for an automatic override.

Example documentation: "Patient trialed adalimumab 40mg every other week for 16 weeks (1/15/24-5/15/24). CDAI remained >220 with no clinical improvement. Discontinued due to treatment failure."

Stability Exception

If you're currently stable on Stelara and switching would be medically inadvisable, you can maintain coverage.

Example documentation: "Patient achieved clinical remission on ustekinumab (CDAI <150 for 8 months). Switching to step therapy agent would risk disease flare."

Clinician Corner: When documenting step therapy failures, include specific dates, doses, duration of trial, objective measures of response (lab values, severity scores), and reason for discontinuation. This creates an airtight case for override approval.

Appeals Playbook for BCBS Ohio

Internal Appeals (First Level)

  • Deadline: 180 days from denial notice
  • How to file: Online via member portal, phone, or written request
  • Timeline: 30 days for standard, 72 hours for urgent
  • What to include: New medical evidence, specialist letters, peer-reviewed studies

External Review (Final Level)

  • Deadline: 180 days from final internal denial
  • How to file: Contact Ohio Department of Insurance at 1-800-686-1526
  • Cost: Free to you
  • Timeline: 30 days standard, 72 hours expedited
  • Success rate: Approximately 50% overturn rate with strong medical evidence

Required Documents for Appeals

  1. Complete denial letter from BCBS
  2. All medical records supporting medical necessity
  3. Provider letter explaining why Stelara is medically necessary
  4. Evidence of prior therapy failures
  5. Relevant clinical guidelines or FDA labeling

Common Denial Reasons & Fixes

Denial Reason How to Overturn Required Documentation
Step therapy not met Prove contraindication or prior failure Medical records, dates, specific outcomes
Not medically necessary Add specialist rationale with guidelines Gastroenterologist/dermatologist letter + ACG/AAD citations
Insufficient documentation Submit comprehensive records Labs, imaging, severity scores, prior authorizations
Non-formulary status Request formulary exception Prove medical necessity and alternatives unsuitable
Quantity limits exceeded Justify higher dose/frequency Weight-based dosing calculations, treatment response data

External Review & Ohio Consumer Protections

Ohio's external review process is particularly consumer-friendly. Unlike many states, Ohio allows the Department of Insurance to independently determine eligibility even if your insurer claims you don't qualify for external review.

Key protections:

  • No minimum dollar amount required for review
  • Independent Review Organizations (IROs) are randomly assigned
  • IRO decisions are binding on your insurer
  • You can submit additional evidence during the review
  • Expedited review available for urgent medical needs

Counterforce Health helps patients navigate these complex appeal processes by analyzing denial letters, identifying the specific denial basis, and drafting targeted rebuttals that align with both payer policies and state regulations. Their platform streamlines the evidence-gathering process and ensures appeals meet all procedural requirements.

Filing Your External Review

  1. Contact Ohio DOI: Call 1-800-686-1526 or visit insurance.ohio.gov
  2. Submit request: Can be oral, written, or electronic (written confirmation required for oral requests)
  3. Include documentation: Medical records, provider recommendations, treatment guidelines
  4. Track progress: ODI will notify you of IRO assignment and review timeline

Costs & Savings Options

Manufacturer Support

Janssen CarePath Program

  • Copay assistance: As low as $5 per dose for eligible patients
  • Eligibility: Commercial insurance, not Medicare/Medicaid
  • Apply: JanssenCarePath.com or 1-877-227-3728

Patient Assistance Programs

  • Income-based: Free medication for qualifying low-income patients
  • Bridge programs: Temporary coverage during appeal process
  • Foundation grants: Independent Charities of America, Patient Advocate Foundation
From Our Advocates: We've seen patients successfully combine Ohio's step therapy protections with manufacturer assistance programs. One patient used the contraindication exception (due to hepatitis B) while enrolling in CarePath, reducing their out-of-pocket costs from $1,200 to $5 per injection during the appeal process.

When to Escalate

Contact the Ohio Department of Insurance immediately if:

  • BCBS doesn't respond within required timeframes
  • You're told external review isn't available when it should be
  • The insurer requests the same documentation repeatedly
  • Your urgent/expedited request isn't processed within 72 hours

Ohio DOI Consumer Hotline: 1-800-686-1526
Online complaints: insurance.ohio.gov complaint portal

For complex cases involving multiple denials or procedural violations, consider contacting UHCAN Ohio for additional consumer advocacy support.

FAQ

How long does BCBS Ohio prior authorization take? Standard PA requests: 72 hours. Urgent requests: 24-72 hours. If BCBS doesn't respond within these timeframes, you can file a complaint with Ohio DOI.

What if Stelara is non-formulary on my plan? You can request a formulary exception by proving medical necessity and that formulary alternatives are unsuitable. Include documentation of contraindications or failures with preferred drugs.

Can I request an expedited appeal? Yes, if waiting for standard review would seriously jeopardize your health. Your physician must certify the urgent medical need. Expedited reviews are completed within 72 hours.

Does step therapy apply if I was stable on Stelara with another insurer? Ohio law protects patients who are stable on current therapy. Provide documentation of your treatment history and current clinical stability to qualify for the stability exception.

What happens during a peer-to-peer review? Your prescribing physician speaks directly with a BCBS medical director to discuss your case. This often resolves denials when the medical director understands the full clinical picture.

How much does external review cost? External review through Ohio DOI is completely free to patients. The state and your insurer cover all costs.

Can I continue Stelara during an appeal? If you're currently on Stelara and BCBS stops coverage, you may be able to continue treatment during appeal under Ohio's continuity of care provisions. Contact member services immediately.

What if my employer plan is self-funded? Self-funded ERISA plans aren't subject to Ohio state law but often follow similar processes voluntarily. Check with your HR department about your plan's specific appeal rights and procedures.

Medical Disclaimer: This information is for educational purposes only and doesn't constitute medical advice. Always consult your healthcare provider about treatment decisions and work with them on insurance authorization requests.

Sources & Further Reading:

For personalized assistance with your Stelara appeal, Counterforce Health provides comprehensive support in analyzing denial letters and crafting evidence-backed appeals that align with payer-specific requirements and Ohio state protections.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.